ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,064.20
0.91%
US Tech 100
17,185.60
0.64%
다우존스 지수
38,225.66
0.85%
Bitcoin
59,315.30
0.33%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Citius Pharmaceuticals Inc (CTXR)

  7. Citius Pharmaceuticals Inc (CTXR) 뉴스

CTXR Citius Pharmaceuticals Inc

0.707
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Citius Pharmaceuticals Inc CTXR 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 0.707 17:00:00
개장가 저가 고가 종가 전일 종가
0.707
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202405:05PRNUSCitius Pharmaceuticals Announces Closing of $15 Million..
26/04/202421:00PRNUSCitius Pharmaceuticals Announces $15 Million Registered..
11/04/202421:30PRNUSCitius Pharmaceuticals Announces Addition of City of Hope to..
04/04/202421:30PRNUSCitius Pharmaceuticals to Present at the LD Micro..
18/03/202421:30PRNUSCitius Pharmaceuticals Announces FDA Acceptance of the BLA..
07/03/202422:30PRNUSCitius Pharmaceuticals, Inc. Secures $2.4 million through..
04/03/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
26/02/202421:30PRNUSCitius Pharmaceuticals Announces Filing of Form S-3 Shelf..
24/02/202406:23EDGAR2Form S-3 - Registration statement under Securities Act of..
24/02/202406:18EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/02/202422:30PRNUSCitius Pharmaceuticals to Participate in Upcoming BIO CEO..
15/02/202422:45EDGAR2Form 8-K - Current report
15/02/202406:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/02/202406:30PRNUSCitius Pharmaceuticals, Inc. Reports Fiscal First Quarter..
14/02/202423:18EDGAR2Form 8-K - Current report
14/02/202422:01PRNUSCitius Pharmaceuticals Resubmits the Biologics License..
27/01/202406:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
27/01/202406:05EDGAR2Form DEF 14A - Other definitive proxy statements
24/01/202406:05EDGAR2Form 8-K - Current report
23/01/202422:30PRNUSCitius Pharmaceuticals Announces Nomination of..
06/01/202406:05EDGAR2Form 8-K - Current report
03/01/202406:04EDGAR2Form 8-K - Current report
02/01/202422:31PRNUSCitius Pharmaceuticals Completes Enrollment in Pivotal Phase..
02/01/202422:30PRNUSCitius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023..
30/12/202306:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
09/11/202322:30PRNUSCitius Pharmaceuticals to Participate in the Sidoti..
31/10/202321:45PRNUSCitius Pharmaceuticals Announces Publication in Frontiers of..
24/10/202320:58EDGAR2Form 425 - Prospectuses and communications, business..
24/10/202320:53EDGAR2Form 8-K - Current report
24/10/202320:30PRNUSCitius Pharmaceuticals Executes Definitive Agreement to..
13/10/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/09/202305:30EDGAR2Form 8-K - Current report
21/09/202322:35GLOBEDawson James Securities Announces October Date for 8th..
19/09/202305:30PRNUSCitius Pharmaceuticals Reschedules Participation in Sidoti..
16/09/202305:30EDGAR2Form 8-K - Current report
14/09/202305:30PRNUSCitius Pharmaceuticals Mourns the Loss of Board Member,..
11/09/202322:53EDGAR2Form 8-K - Current report
08/09/202321:40EDGAR2Form 8-K - Current report
08/09/202321:00PRNUSCitius Pharmaceuticals, Inc. Receives Regulatory Guidance..
07/09/202305:30PRNUSCitius Pharmaceuticals to Participate in H.C. Wainwright and..
15/08/202322:25EDGAR2Form 8-K - Current report
15/08/202305:15PRNUSCitius Pharmaceuticals, Inc. Reports Fiscal Third Quarter..
15/08/202305:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202305:15EDGAR2Form 8-K - Current report
10/08/202321:37PRNUSCitius Pharmaceuticals Reaches 92 Event Milestone in..
01/08/202305:15EDGAR2Form 8-K - Current report
30/07/202305:16PRNUSCitius Pharmaceuticals, Inc. Receives a Complete Response..

최근 히스토리

NASDAQ
CTXR
Citius Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유